OUR PRODUCTS

MOBILE APPS

GENERAL INFO

EXEL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Exelixis (EXEL) Earnings Date & Reports

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EXEL is expected to report earnings to fall 9.05% to 68 cents per share on November 04

Q3'25

Est.

$0.68

Q2'25

Beat

by $0.11

Q1'25

Beat

by $0.25

Q4'24

Beat

by $0.16

Q3'24

Beat

by $0.13

The last earnings report on July 28 showed earnings per share of 75 cents, beating the estimate of 63 cents. With 2.37M shares outstanding, the current market capitalization sits at 10.31B.

View a ticker or compare two or three

Compare

EXEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EXEL
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EXEL showed earnings on July 28, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1851 Harbor Bay Parkway

Phone

+1 650 837-7000

Employees

1310

Web

https://www.exelixis.com